These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5487969)

  • 21. Treatment of cardiogenic shock. 1.
    Cohen LS
    Calif Med; 1973 Jan; 118(1):74-6. PubMed ID: 4685952
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucagon? One answer to cardiogenic shock.
    Deraney MF
    Am J Med Sci; 1971 Mar; 261(3):149-54. PubMed ID: 4326665
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of cardiogenic shock. I.
    Cohen LS
    Md State Med J; 1972 Sep; 21(9):26-8. PubMed ID: 5054523
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiotonic effect of glucagon].
    Robert M; Humair L
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:123-6. PubMed ID: 5288597
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucagon: a new agent for the treatment of low cardiac output syndromes.
    Kones RJ
    Jpn Heart J; 1972 May; 13(3):266-71. PubMed ID: 4538258
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of glucagon by continuous perfusion in the treatment of shock states].
    Bernard S; Duchesne G; Herman B
    Presse Med (1893); 1971 Feb; 79(7):267-70. PubMed ID: 5576150
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiovascular effects of glucagon].
    Seitz N
    Internist (Berl); 1971 May; 12(5):222-3. PubMed ID: 4931507
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of cardiogenic shock. I.
    Cohen LS
    J Maine Med Assoc; 1972 Sep; 63(9):212-3. PubMed ID: 5068938
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucagon: hormone or therapeutic agent?
    Hall-Boyer K; Zaloga GP; Chernow B
    Crit Care Med; 1984 Jul; 12(7):584-9. PubMed ID: 6375966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of glucagon-induced changes in rate, contractility and cyclic AMP levels in isolated cardiac preparations of the rat and guinea pig.
    MacLeod KM; Rodgers RL; McNeill JH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):798-804. PubMed ID: 6262497
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
    Mehta RH; Califf RM; Yang Q; Pieper KS; White HD; Ohman EM; Harrington RA; Granger CB
    Am J Cardiol; 2007 Mar; 99(6):793-6. PubMed ID: 17350367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucagon on myocardial contractility and cardiac output.
    Hamer J; Gibson D; Coltart J
    Br Heart J; 1972 Feb; 34(2):204. PubMed ID: 5007807
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of glucagon on the circulatory system].
    Kedrowa S
    Pol Tyg Lek; 1971 Jul; 26(30):1172-4. PubMed ID: 4937316
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of glucagon in toxic cardiogenic shock].
    Mofredj A; Rakotondrantoanina JR; Baraka D
    Ann Fr Anesth Reanim; 1999 Nov; 18(9):1024-5. PubMed ID: 10615555
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodynamic effect of glucagon in patients with chronic complete heart block.
    Gavrilescu S; Streian C; Pop T; Vicas E
    Cor Vasa; 1971; 13(2):85-91. PubMed ID: 5570405
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular laboratory Duke Hospital.
    Parmley WW; Sonnenblick EH
    N Engl J Med; 1968 Aug; 279(8):435. PubMed ID: 5663195
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action and significance of glucagon in surgery].
    Przybyszowski A; Lejman W
    Pol Przegl Chir; 1978 Dec; 50(12):1091-6. PubMed ID: 751028
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiovascular action of a pancreatic hormone: glucagon].
    Domínguez de Villota E
    Rev Clin Esp; 1974 Jun; 133(6):471-4. PubMed ID: 4612639
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiogenic shock caused by metoprolol poisoning. Reversibility with high doses of glucagon and isoproterenol].
    Gabry AL; Pourriat JL; Hoang TD; Lapandry C
    Presse Med; 1985 Feb; 14(4):229. PubMed ID: 3156367
    [No Abstract]   [Full Text] [Related]  

  • 40. A review of potential cardiovascular uses of intravenous glucagon administration.
    White CM
    J Clin Pharmacol; 1999 May; 39(5):442-7. PubMed ID: 10234590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.